DeVon Barnett

Cooley advised Thirty Madison, a specialty healthcare company for people living with chronic conditions, on its agreement to merge with female-focused digital healthcare company Nurx. Partners Ian Nussbaum and Adam Dinow led the Cooley team advising Nurx. 

Cooley advised Esusu, a leading fintech platform leveraging data to empower renters and improve property performance, on its $130 million Series B led by SoftBank Vision Fund 2, which brings the company to a $1 billion valuation. This latest fundraise makes Esusu one of the few Black-owned startups to reach unicorn status both in the US and globally. DeVon Barnett, Jeff Laretto, Tanisha James and Pat O’Connell led the Cooley team advising Esusu.

Cooley advised Packable, the holding company for technology-led ecommerce marketplace enablement platform Pharmapacks, on its definitive agreement to merge with special purpose acquisition company (SPAC) Highland Transcend Partners I Corp. Partners Sacha Ross, David Silverman, Nicolas Dumont and Stephanie Gentile led the Cooley team advising Packable.

Cooley advised Thirty Madison, a healthcare company for people with chronic conditions, on its $140 million Series C financing round, which brings its valuation to more than $1 billion. Lawyers Adam Dinow, Scott Rudin and DeVon Barnett led the Cooley team advising Thirty Madison.

Cooley advised Celularity, a clinical-stage biotechnology company developing off-the-shelf allogeneic therapies derived from the postpartum human placenta, on its agreement to become a public company by merging with GX Acquisition Corp., a special purpose acquisition company. Upon closing of the transaction, which is expected in Q2, GX will be renamed Celularity, and its common stock and warrants are anticipated to remain listed on Nasdaq under the new ticker symbols “CELU” and “CELUW.” Yvan-Claude Pierre, Marc Recht, Kevin Cooper and Marianne Sarrazin led the Cooley team advising Celularity on the transaction.

Read more